Overview
Facial nerve schwannomas (FNSs) are rare, benign tumors originating from Schwann cells of the facial nerve, often requiring conservative management due to their infiltrative nature 1.Diagnosis
Clinical Presentation: Mild facial paresis or dysfunction 1.
Imaging: MRI is essential for detailed tumor characterization and extent 1.
Histopathology: Definitive diagnosis through surgical biopsy or resection 1.Management
First-Line Treatment: Watchful waiting for asymptomatic or slowly progressing tumors 1.
Stereotactic Radiosurgery (SRS): Effective for stabilizing or shrinking tumors, improving facial nerve function 1.
Surgical Intervention: Reserved for cases with significant neurological deficits, complications like hemorrhage, or failure of SRS 1.Special Populations
Elderly: SRS can be considered as a less invasive alternative to surgery, though complications like hemorrhage must be monitored 1.Key Recommendations
Stereotactic radiosurgery is a reasonable alternative to microsurgical resection for managing facial nerve schwannomas, offering potential benefits in preserving facial nerve function 1 (Evidence: Moderate).
Close monitoring is necessary post-SRS due to potential complications such as acute hemorrhage requiring urgent intervention 1 (Evidence: Weak).
Surgical intervention should be considered in cases of neurological deterioration, treatment failure, or severe complications like brainstem compression 1 (Evidence: Expert opinion).References
1 Noureldine MHA, Jha RT, Peto I, Malafronte PJ, Allen K, Agazzi S. Facial Nerve Schwannoma Complicated by Acute Hemorrhage After Treatment with Stereotactic Radiosurgery. World neurosurgery 2020. link